25.94 USD
↗ 0.30 (1.17%)AT CLOSE (11:59 AM EDT)
Catalyst Pharmaceutical Inc.
CPRXNASDAQ • USD
25.94
↘ 0.01 (0.02%)
POST MARKET (AS OF 07:51 PM EDT)
Post Market
AS OF 07:51 PM EDT
25.94
↘ 0.01 (0.02%)
Market: CLOSED
Open?$25.82
High?$25.96
Low?$25.55
Prev. Close?$25.64
Volume?703.3K
Avg. Volume?1.2M
VWAP?$25.82
Rel. Volume?0.57x
Bid / Ask
Bid?$22.07 × 100
Ask?$29.20 × 100
Spread?$7.13
Midpoint?$25.63
Valuation & Ratios
Market Cap?3.1B
Shares Out?122.1M
Float?114.3M
Float %?93.0%
P/E Ratio?14.61
P/B Ratio?3.28
EPS?$1.75
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?6.08Strong
Quick Ratio?5.82Strong
Cash Ratio?4.82Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUED
Score83/100
P/E?14.6CHEAP▾
P/B?3.28FAIR▾
P/S?5.32FAIR▾
P/FCF?15.0CHEAP▾
EV/EBITDA?8.2CHEAP▾
EV/Sales?4.11FAIR▾
Returns & Efficiency
ROE?22.5%STRONG▾
ROA?19.4%STRONG▾
Cash Flow & Enterprise
FCF?$208.6M
Enterprise Value?$2.4B
News
Profile
Catalyst Pharmaceuticals Inc is a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare and difficult to treat diseases. The Company sells three commercial stage drug products, FIRDAPSE (amifampridine), AGAMREE (vamorolone), and FYCOMPA (perampanel). The Company is currently seeking to further expand its product portfolio, with a focus on acquiring the rights to immediately and near-term accretive assets to treat rare (orphan) diseases across therapeutic areas, including clinical-stage opportunities with established proof of concept.
Employees
182
Market Cap
3.1B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2006-11-08
Address
355 ALHAMBRA CIRCLE
CORAL GABLES, FL 33134
Phone: (305) 529-2522
CORAL GABLES, FL 33134
Phone: (305) 529-2522